BioCentury
Brought To You By Pathfinder Partner
SOFINNOVA INVESTMENTS
Since its incorporation in California over four decades ago, Sofinnova Investments has a long legacy of partnering with entrepreneurs to improve quality of life for patients through financing the development of innovative and potentially life-saving therapeutics.
WEBCAST | Product Development

Getting real with Amy Abernethy on The BioCentury Show

Verily’s president of Clinical Studies Platforms discusses how the company is combining real-world and clinical data to produce actionable evidence

May 19, 2022 2:12 PM UTC

Amy Abernethy has focused her career as an academic researcher, as CMO and CSO at Flatiron Health, as a senior FDA official, and now as president of clinical studies platforms at Verily Life Sciences on making real the vision of a learning healthcare system.

In a conversation with The BioCentury Show, Abernethy described some of the projects Verily is undertaking, as well as its overall strategy. The company, she said, is building systems to combine real-world data with data from clinical trials to answer clinical questions that physicians and patients can act on and that inform medical product development and public health. ...





Complimentary access available. Register for a free account.

Already have an account? Log in

BCIQ Company Profiles

Verily Life Sciences LLC